Whole brain radiotherapy plus concurrent chemotherapy in non-small cell lung cancer patients with brain metastases: a meta-analysis.

Whole brain radiotherapy plus concurrent chemotherapy in non-small cell lung cancer patients with brain metastases: a meta-analysis.

The aim of the present meta-analysis is to evaluate the response rate, median survival time (MST) and toxicity in patients with brain metastases (BM) originating from non-small cell lung cancer (NSCLC) and who were treated using either whole brain radiotherapy (WBRT) plus concurrent chemotherapy or...

Full description

Bibliographic Details
Main Authors:	Hong Qin, Feng Pan, Jianjun Li, Xiaoli Zhang, Houjie Liang, Zhihua Ruan
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4210217?pdf=render

Similar Items

Brain Radiotherapy plus Concurrent Temozolomide versus Radiotherapy Alone for Patients with Brain Metastases: A Meta-Analysis.
by: Qian Zhao, et al.
Published: (2016-01-01)

Whole brain radiotherapy with radiosensitizer for brain metastases
by: Viani Gustavo, et al.
Published: (2009-01-01)

Combining Whole-Brain Radiotherapy with Gefitinib/Erlotinib for Brain Metastases from Non-Small-Cell Lung Cancer: A Meta-Analysis
by: Mao-hua Zheng, et al.
Published: (2016-01-01)

Upfront whole brain radiotherapy for multiple brain metastases in patients with EGFR-mutant lung adenocarcinoma
by: Li C, et al.
Published: (2019-04-01)

Whole Brain Radiotherapy Combined with Simultaneous Integrated Boost for Brain Metastases of Lung Cancer: Its Clinical Effectiveness and Prognosis
by: HE Jun, et al.
Published: (2018-08-01)

Brain Radiotherapy Combined with Sequential Chemotherapy in Non-Small-Cell Lung Cancer Patients with Brain Metastases
by: Likun CHEN, et al.
Published: (2009-08-01)

Survival and effective prognostic factors in lung cancer patients with brain metastases treated with whole brain radiotherapy
by: Bixin Ren, et al.
Published: (2021-03-01)

Timing of Whole Brain Radiotherapy on Survival of Patients with EGFR-mutated  Non-small Cell Lung Cancer and Brain Metastases
by: Guimei LIU, et al.
Published: (2016-08-01)

Single institutional outcomes of whole brain radiotherapy for metastatic melanoma brain metastases
by: Cecilia Jiang, et al.
Published: (2021-02-01)

Best Supportive Care Versus Whole-Brain Irradiation, Chemotherapy Alone, or WBRT Plus Chemotherapy in Patients With Brain Metastases From Small-Cell Lung Cancer: A Case-Controlled Analysis
by: Hongwei Li, et al.
Published: (2021-03-01)

Whole Brain Irradiation and Hypo-fractionation Radiotherapy for the Metastases in Non-small Cell Lung Cancer
by: Xingting GU, et al.
Published: (2016-04-01)

Phase II study of whole brain radiotherapy with or without erlotinib in patients with multiple brain metastases from lung adenocarcinoma
by: Zhuang H, et al.
Published: (2013-10-01)

Neurocognitive function impairment after whole brain radiotherapy for brain metastases: actual assessment
by: Tallet Agnes V, et al.
Published: (2012-05-01)

Whole‐brain radiotherapy plus sequential or simultaneous integrated boost for the treatment of a limited number of brain metastases in non‐small cell lung cancer: A single‐institution study
by: Dong Qing, et al.
Published: (2020-01-01)

Survival and intracranial control outcomes of whole-brain radiotherapy (WBRT) alone versus WBRT plus a radiotherapy boost in non-small-cell lung cancer with brain metastases: a single-institution retrospective analysis
by: Lu F, et al.
Published: (2019-05-01)

Efficacy and Safety of Radiotherapy Plus EGFR-TKIs in NSCLC Patients with Brain Metastases: A Meta-Analysis of Published Data
by: Xueyan Wang, et al.
Published: (2018-10-01)

Whole-Brain Radiotherapy vs. Localized Radiotherapy after Resection of Brain Metastases in the Era of Targeted Therapy: A Retrospective Study
by: Jaho Koo, et al.
Published: (2021-09-01)

From Whole-Brain Radiotherapy to Immunotherapy: A Multidisciplinary Approach for Patients with Brain Metastases from NSCLC
by: Maria Protopapa, et al.
Published: (2019-01-01)

A Case of Brain Metastases from Breast Cancer Treated with Whole-Brain Radiotherapy and Eribulin Mesylate
by: Carsten Nieder, et al.
Published: (2012-01-01)

Whole brain radiotherapy (WBRT) after local treatment of brain metastases in melanoma patients: Statistical Analysis Plan
by: Serigne N. Lo, et al.
Published: (2019-08-01)

A Clinical Observation of Concomitant Therapy of Erlotinib and Whole Brain Radiotherapy in Patients of NSCLC Combined with Brain Metastases
by: Lihong ZHANG, et al.
Published: (2009-12-01)

Whole brain radiotherapy for brain metastases from breast cancer: estimation of survival using two stratification systems
by: Guimarães Flavio S, et al.
Published: (2007-03-01)

Distribution of brain metastases: low-risk metastasis areas may be avoided when treating with whole-brain radiotherapy
by: Binwei Lin, et al.
Published: (2020-04-01)

Incidence of Hippocampal Metastases: Laterality and Implications for Unilateral Hippocampal Avoiding Whole Brain Radiotherapy
by: Tomas Kazda, et al.
Published: (2018-01-01)

Computer Tomography Radiomics-Based Nomogram in the Survival Prediction for Brain Metastases From Non-Small Cell Lung Cancer Underwent Whole Brain Radiotherapy
by: Ji Zhang, et al.
Published: (2021-02-01)

Clinical Response to Apatinib Combined With Brain Radiotherapy in EGFR Wild-Type and ALK-Negative Lung Adenocarcinoma With Multiple Brain Metastases
by: Xiaofang Ying, et al.
Published: (2020-04-01)

Stereotactic Cavity Irradiation or Whole-Brain Radiotherapy Following Brain Metastases Resection—Outcome, Prognostic Factors, and Recurrence Patterns
by: Rami A. El Shafie, et al.
Published: (2020-05-01)

Analysis of Prognostic Factors in NSCLC Patients with Brain Metastases  Diagnosed by Constrast-enhanced MRI After Whole Brain Radiotherapy
by: Hui LIU, et al.
Published: (2011-09-01)

Whole brain radiotherapy after local treatment of brain metastases in melanoma patients - a randomised phase III trial
by: Forder Peta M, et al.
Published: (2011-04-01)

Success of Crizotinib Combined with Whole-Brain Radiotherapy for Brain Metastases in a Patient with Anaplastic Lymphoma Kinase Rearrangement-Positive Non-Small-Cell Lung Cancer
by: Sachi Okawa, et al.
Published: (2018-11-01)

Efficacy and toxicity of whole brain radiotherapy in patients with multiple cerebral metastases from malignant melanoma
by: Hauswald Henrik, et al.
Published: (2012-08-01)

Whole Brain Radiation Therapy Plus Focal Radiation Boost May Generate Better Survival Benefit for Brain Metastases From Non-small Cell Lung Cancer
by: Meng Ni, et al.
Published: (2020-10-01)

Different Fractionation in Whole Brain Irradiation for Multiple Brain Metastases
by: Mona Mahmoud Sayed
Published: (2015-04-01)

Whole brain radiotherapy versus stereotactic radiosurgery for 4–10 brain metastases: a phase III randomised multicentre trial
by: Jaap D. Zindler, et al.
Published: (2017-07-01)

Risk factors for brain metastases in surgically staged IIIA non-small cell lung cancer patients treated with surgery, radiotherapy and chemotherapy
by: Petrović Marina, et al.
Published: (2011-01-01)

Radiotherapy plus concurrent or sequential temozolomide for glioblastoma in the elderly: a meta-analysis.
by: An-an Yin, et al.
Published: (2013-01-01)

Repeated Courses of Radiosurgery for New Brain Metastases to Defer Whole Brain Radiotherapy: Feasibility and Outcome With Validation of the New Prognostic Metric Brain Metastasis Velocity
by: Corinna Fritz, et al.
Published: (2018-11-01)

Whole Brain Radiation Therapy Plus Stereotactic Radiosurgery in the Treatment of Brain Metastases Leading to Improved Survival in Patients With Favorable Prognostic Factors
by: Muhammad Khan, et al.
Published: (2019-03-01)

Comparing the efficacy of concurrent EGFR-TKI and whole-brain radiotherapy vs EGFR-TKI alone as a first-line therapy for advanced EGFR-mutated non-small-cell lung cancer with brain metastases: a retrospective cohort study
by: He ZY, et al.
Published: (2019-03-01)

Effects of Whole-brain Radiotherapy Combined with Targeted Therapy on Improving Survival of HER2-positive Breast Cancer Patients with Brain Metastases
by: LI Zhensheng, et al.
Published: (2018-11-01)